INOZYME PHARMA INC shareholders Q2 2023

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 74 filers reported holding INOZYME PHARMA INC in Q2 2023. The put-call ratio across all filers is 2.65 and the average weighting 0.2%.

INOZYME PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
GEODE CAPITAL MANAGEMENT, LLC 617,459$3,439,2460.00%
STATE STREET CORP 560,842$3,123,8900.00%
NEW YORK STATE COMMON RETIREMENT FUND 17,100$950.00%
CITIGROUP INC 10,080$56,1460.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 88,257$491,5910.00%
GOLDMAN SACHS GROUP INC 34,389$191,5470.00%
MORGAN STANLEY 33,585$187,0690.00%
Invesco Ltd. 13,048$72,6780.00%
AMALGAMATED BANK 3,292$180.00%
BlackRock Inc. 1,939,660$10,803,9060.00%
Bank of New York Mellon Corp 141,704$789,2910.00%
Citadel Advisors 3,000$16,7100.00%
Citadel Advisors 21,100$117,5270.00%
Citadel Advisors 145,600$810,9920.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 14,600$81,3220.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 25,500$142,0350.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 16,404$91,3700.00%
SIMPLEX TRADING, LLC 72$00.00%
External links

This page lists INOZYME PHARMA INC's shareholders in Q2 2023. To view INOZYME PHARMA INC's shareholder history, click here.